Skip to main content
Clinical Trials/CTRI/2024/04/064979
CTRI/2024/04/064979
Not Yet Recruiting
N/A

Comparative Evaluation Of Therapeutic Efficacy And Safety Of Intranasal Fluticasone Furoate And Fluticasone Propionate In Patients Of Chronic Rhinosinusitis: A Randomized, Open Label, Parallel Group Study - nil

Govt Doon Medical college0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: J329- Chronic sinusitis, unspecifiedHealth Condition 2: J329- Chronic sinusitis, unspecified
Sponsor
Govt Doon Medical college
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Govt Doon Medical college

Eligibility Criteria

Inclusion Criteria

  • 1\.Newly diagnosed cases of chronic rhinosinusitis in age group of 18\-60 years .
  • 2\. Patients giving valid informed consent.

Exclusion Criteria

  • 1\. Cases having active upper air way infection, malignant / benign mass of nose and PNS and post\-operative cases of functional endoscopic sinus surgery.
  • 2\. Patient having symptomatic gross Deviated Nasal Septum(DNS),Septal perforation and/or Nasal polyps, severe epistaxis, purulent nasal infection
  • 3\. Patients refusing to participate in the study.
  • 4\. Dependence on prolonged corticosteroid therapy for comorbid conditions, such as asthma and chronic obstructive pulmonary disease
  • 5\. History of allergy to fluticasone propionate or fluticasone furoate or other topical steroids.
  • 6\. History of clinically significant cardiac, renal, psychiatric, hepatic and endocrine disease.
  • 7\. Pregnant or breastfeeding females.
  • 8\. Known immunodeficiency state.
  • 9\. Patients of Fungal Rhinosinusitis.

Outcomes

Primary Outcomes

Not specified

Similar Trials